EVISA - Who we are
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
Information - Pharmacy/Pharmacology
Cisplatin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Cisplatin is classified as an "alkylating agent." (For more detail, see "How Cisplatin Works" section below).
See the complete list of deadlines!
ISCC 2020: 44th International Symposium on Capillary Chromatography
Riva del Garda, Italy
68th ASMS Conference
Second Workshop on Laser Bioimaging Mass Spectrometry - BI(MS)2 2020
... more Events
What's new on EVISA's web site ?
Call for Contributions to a Special Issue of Frontiers in Chemistry: Advances in Analytical Techniques and Methodology for Chemical Speciation Study
Determination of arsenic species in water by means of capillary electrophoresis coupled to electrospray mass spectrometry
Arsenic speciation analysis in rice milk
Half of the rice sold in the UK breaches limits on arsenic for children
... more News
You have forgotten your password ?
© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )